查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1365749

动物模型市场：按动物类型、应用、最终用户：2023-2032 年全球机会分析和产业预测

Animal Model Market By Animal Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 295 Pages | 商品交期: 2-3个工作天内

价格

2022年动物模型市值为19亿美元，预计2023年至2032年年复合成长率为6.6%，2032年达36亿美元。

动物模型市场-IMG1

疫苗是预防和控制感染疾病最有效、最经济的工具。由于 SARS-CoV-2 的快速传播、临床病例、结果的变异性以及高死亡率，世界卫生组织 (WHO) 于 2020 年 1 月将 COVID-19 列为国际关注的公共卫生问题。2020 年 3 月宣布进入紧急状态和大流行，开发药物治疗方法和疫苗的竞赛已经开始。在 COVID-19 疫苗开发中，使用和选择可靠且特征良好的实验模型对于加快研究并最终实现疫苗註册和可用性至关重要。根据美国国家医学图书馆 2021 年的报告，参与 COVID-19 研究的动物模型包括小鼠、金仓鼠、雪貂、非灵长类动物和猪。超过302种疫苗正在研发中，其中117种已成功进入临床试验。因此，在感染疾病疫苗的市场开拓中越来越多地使用动物模型预计将显着促进市场成长。

CRISPR（成簇规律间隔短回文重复序列）技术的日益普及已成为动物模型市场的主要驱动力。 CRISPR 技术让科学家可以对包括动物在内的多种生物体的 DNA 进行有针对性的修改，从而实现精确、高效的基因组编辑。这种突破性的基因编辑工具极大地推进了遗传学和医学研究领域，在动物模型的创建方面提供了许多应用。此外，使用 CRISPR 技术建立的动物模型对于新药的发现至关重要。这项技术创造了高度客製化的小鼠和大鼠，其 DNA 已被修改以反映人性化的免疫系统，从而可以在研究和靶向中进行精确建模，还可以检验和评估有效性。在使用这项技术之前，生成实验动物需要长达18个月的时间，但现在生成创始动物只需三分之一到二分之一的时间，而其他临床前动物模型比动物模型更具成本效益。因此，CRISPR 的广泛普及和使用小鼠模型的研究的增加预计将推动市场成长。例如，2020年美国医疗健康研发投入成长11.1%，达到2,451亿美元。增加在药物开发过程中有效利用小鼠模型的研究活动预计将推动市场成长。然而，有关在研究中使用动物的道德准则预计将限制动物模型市场的成长。

全球动物模型市场按动物类型、应用、最终用户和地区细分。依动物种类分为大鼠、小鼠、豚鼠、兔等。其他包括斑马鱼、两栖类/爬虫类、仓鼠、龙猫、沙鼠、犰狳等。依应用领域分为药物研发发现/研发、基础研究等。其他领域包括医疗设备研发、生产和品管等。依最终用户划分，可分为製药/生物公司、学术研究机构等。其他包括医疗设备公司、CRO（合约药物委外研发机构）和受託製造厂商。从区域来看，我们对北美、欧洲、亚太地区和拉丁美洲/中东/非洲的市场进行了分析。

目录

第1章简介

第2章执行摘要

第3章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
      • 动物模型在病毒学和感染疾病的使用增加
      • 药物测试中人类与动物的生理相似性
      • CRISPR 技术的采用增加
    • 抑制因素
      • 替代测试方法的可用性
    • 机会
      • 新兴市场的成长机会

第4章动物模型市场：依动物类型

  • 概述
  • 鼠
  • 老鼠
  • 天竺鼠
  • 兔子
  • 其他的

第5章动物模型市场：依应用分类

  • 概述
  • 药物研发/研究与开发
  • 基础研究
  • 其他的

第6章动物模型市场：依最终使用者分类

  • 概述
  • 製药/生物公司
  • 学术研究所
  • 其他的

第7章动物模型市场：依地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 澳洲
    • 印度
    • 韩国
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第8章竞争形势

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争仪表板
  • 竞争热图
  • 2022年主要企业定位

第9章公司简介

  • Charles River Laboratories
  • Inotiv, Inc.
  • Genoway SA
  • Hera Biolabs
  • Crown Bioscience Inc.
  • Ozgene Pty Ltd.
  • Taconic Biosciences
  • The Jackson Laboratory.
  • Trans Genic Inc.
  • Janvier Labs, LLC
Product Code: A07946

According to a new report published by Allied Market Research, titled, "Animal Model Market," The animal model market was valued at $1.9 billion in 2022, and is estimated to reach $3.6 billion by 2032, growing at a CAGR of 6.6% from 2023 to 2032.

Animal Model Market - IMG1

Vaccines are the most effective and economical tools in preventing and controlling infectious diseases. Owing to the rapid spread of SARS-CoV-2, the variability among clinical cases, their outcomes, and high mortality rates, a race to find pharmacological treatments and vaccines was initiated once the World Health Organization (WHO) declared COVID-19 a public health emergency of international concern in January 2020 and a pandemic in March 2020. In context, of vaccine development for COVID-19, the use and choice of reliable and well-characterized experimental models were important for the rapid advancement of research and, consequently, the registration and availability of the vaccines. According to a 2021 report by the National Library of Medicines, animal models involved in the study of COVID-19 include mice, golden hamsters, ferrets, nonhuman primates, and pigs. More than 302 vaccines were under development, of which 117 of them have successfully entered clinical trials. Thus, increase in usage of animal models in the development of vaccines for infectious diseases is expected to contribute significantly in the growth of the market.

Increased adoption of CRISPR (clustered regularly interspaced short palindromic repeats) technology has emerged as a major driver of the animal model market. CRISPR technology allows for precise and efficient genome editing by enabling scientists to make targeted modifications in the DNA of various organisms, including animals. This revolutionary gene-editing tool has significantly advanced the field of genetics and biomedical research, offering numerous applications in the creation of animal models. Furthermore, animal models generated by CRISPR technology have been crucial in the discovery of new medicines. This technology generates highly customized mice and rats whose DNA has been altered to reflect a humanized immune system, which enables precision modeling in research as well as target validation and efficacy assessment. Prior to the use of this technology, it took up to 18 months to produce test animals, whereas now it takes anywhere from one-third to one-half the time to create a founder animal, making it more cost-effective than alternative preclinical animal models. Thus, rise in adoption CRISPR and increase in mouse model-based research are expected to drive the growth of the market. For instance, the U.S. medical and health research and development investment reached $245.1 billion in 2020, an 11.1% increase in 2020. Increase in research activities in the mice model to effectively use them in drug development process is expected to drive the growth of the market. However, ethical guidelines for the use of animals in research are expected to restrain the growth of the animal model market.

The global animal model market is segmented into animal type, application, end user, and region. On the basis of animal type, the market is categorized into rat, mice, guinea pigs, rabbits, and others. The others include zebrafish, amphibians & reptiles, hamsters, chinchillas, gerbils, and armadillo. By application, the market is divided into drug discovery & development, basic research, and others. The others include medical device development, and production & quality control. Depending on end user, the market is segregated into pharma & biotech companies, academic research institutes, and others. The others segment includes medical device companies, contract research organizations (CROs), and contract manufacturing organizations. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA

The key players that operate in the global animal model market are The Jackson Laboratory, Janvier Labs, LLC, Genoway S.A., Hera Biolabs, Crown Bioscience Inc, Ozgene Pty Ltd., Taconic Biosciences, Trans Genic Inc., Inotiv, Inc., and Charles River Laboratories.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the animal model market analysis from 2022 to 2032 to identify the prevailing animal model market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the animal model market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global animal model market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast

Key Market Segments

By Animal Type

  • Rat
  • Mice
  • Guinea pigs
  • Rabbits
  • Others

By Application

  • Drug discovery and development
  • Basic research
  • Others

By End User

  • Others
  • Pharma and biotech companies
  • Academic research institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • The Jackson Laboratory.
    • Hera Biolabs
    • Janvier Labs, LLC
    • Inotiv, Inc.
    • Charles River Laboratories
    • Taconic Biosciences
    • Crown Bioscience Inc.
    • Ozgene Pty Ltd.
    • Trans Genic Inc.
    • Genoway S.A.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in usage of animal models in virology and infectious diseases
      • 3.4.1.2. Physiological similarity of humans and animals for drug testing
      • 3.4.1.3. Increase in adoption of CRISPR technology
    • 3.4.2. Restraints
      • 3.4.2.1. Availability of alternative testing methods
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets

CHAPTER 4: ANIMAL MODEL MARKET, BY ANIMAL TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Rat
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Mice
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Guinea pigs
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Rabbits
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Others
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: ANIMAL MODEL MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Drug discovery and development
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Basic research
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: ANIMAL MODEL MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Pharma and biotech companies
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Academic research institutes
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: ANIMAL MODEL MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Animal Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Animal Type
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Animal Type
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Animal Type
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Animal Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Animal Type
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Animal Type
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Animal Type
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Animal Type
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Animal Type
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Animal Type
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Animal Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Animal Type
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Animal Type
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Market size and forecast, by Animal Type
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. India
      • 7.4.5.4.1. Market size and forecast, by Animal Type
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Animal Type
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Animal Type
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Animal Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Animal Type
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Animal Type
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Animal Type
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Animal Type
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Charles River Laboratories
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Inotiv, Inc.
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Genoway S.A.
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Key strategic moves and developments
  • 9.4. Hera Biolabs
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
  • 9.5. Crown Bioscience Inc.
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. Ozgene Pty Ltd.
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. Taconic Biosciences
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Key strategic moves and developments
  • 9.8. The Jackson Laboratory.
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Trans Genic Inc.
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. Janvier Labs, LLC
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 02. ANIMAL MODEL MARKET FOR RAT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. ANIMAL MODEL MARKET FOR MICE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. ANIMAL MODEL MARKET FOR GUINEA PIGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. ANIMAL MODEL MARKET FOR RABBITS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. ANIMAL MODEL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. GLOBAL ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 08. ANIMAL MODEL MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. ANIMAL MODEL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 12. ANIMAL MODEL MARKET FOR PHARMA AND BIOTECH COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. ANIMAL MODEL MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. ANIMAL MODEL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. ANIMAL MODEL MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA ANIMAL MODEL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 20. U.S. ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 21. U.S. ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. U.S. ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. CANADA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 24. CANADA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. CANADA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE ANIMAL MODEL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. UK ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 40. UK ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. UK ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. ITALY ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 43. ITALY ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. ITALY ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC ANIMAL MODEL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 55. JAPAN ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. CHINA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 59. CHINA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. CHINA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. AUSTRALIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 62. AUSTRALIA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. AUSTRALIA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. INDIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 65. INDIA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. INDIA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. LAMEA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. LAMEA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. LAMEA ANIMAL MODEL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 77. BRAZIL ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 78. BRAZIL ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. BRAZIL ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. SAUDI ARABIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 81. SAUDI ARABIA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 82. SAUDI ARABIA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. SOUTH AFRICA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH AFRICA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH AFRICA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. REST OF LAMEA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 87. REST OF LAMEA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. REST OF LAMEA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. CHARLES RIVER LABORATORIES: KEY EXECUTIVES
  • TABLE 90. CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT
  • TABLE 91. CHARLES RIVER LABORATORIES: PRODUCT SEGMENTS
  • TABLE 92. CHARLES RIVER LABORATORIES: SERVICE SEGMENTS
  • TABLE 93. CHARLES RIVER LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 94. CHARLES RIVER LABORATORIES: KEY STRATERGIES
  • TABLE 95. INOTIV, INC.: KEY EXECUTIVES
  • TABLE 96. INOTIV, INC.: COMPANY SNAPSHOT
  • TABLE 97. INOTIV, INC.: PRODUCT SEGMENTS
  • TABLE 98. INOTIV, INC.: PRODUCT PORTFOLIO
  • TABLE 99. GENOWAY S.A.: KEY EXECUTIVES
  • TABLE 100. GENOWAY S.A.: COMPANY SNAPSHOT
  • TABLE 101. GENOWAY S.A.: PRODUCT SEGMENTS
  • TABLE 102. GENOWAY S.A.: PRODUCT PORTFOLIO
  • TABLE 103. GENOWAY S.A.: KEY STRATERGIES
  • TABLE 104. HERA BIOLABS: KEY EXECUTIVES
  • TABLE 105. HERA BIOLABS: COMPANY SNAPSHOT
  • TABLE 106. HERA BIOLABS: PRODUCT SEGMENTS
  • TABLE 107. HERA BIOLABS: SERVICE SEGMENTS
  • TABLE 108. HERA BIOLABS: PRODUCT PORTFOLIO
  • TABLE 109. CROWN BIOSCIENCE INC.: KEY EXECUTIVES
  • TABLE 110. CROWN BIOSCIENCE INC.: COMPANY SNAPSHOT
  • TABLE 111. CROWN BIOSCIENCE INC.: PRODUCT SEGMENTS
  • TABLE 112. CROWN BIOSCIENCE INC.: SERVICE SEGMENTS
  • TABLE 113. CROWN BIOSCIENCE INC.: PRODUCT PORTFOLIO
  • TABLE 114. OZGENE PTY LTD.: KEY EXECUTIVES
  • TABLE 115. OZGENE PTY LTD.: COMPANY SNAPSHOT
  • TABLE 116. OZGENE PTY LTD.: PRODUCT SEGMENTS
  • TABLE 117. OZGENE PTY LTD.: SERVICE SEGMENTS
  • TABLE 118. OZGENE PTY LTD.: PRODUCT PORTFOLIO
  • TABLE 119. TACONIC BIOSCIENCES: KEY EXECUTIVES
  • TABLE 120. TACONIC BIOSCIENCES: COMPANY SNAPSHOT
  • TABLE 121. TACONIC BIOSCIENCES: PRODUCT SEGMENTS
  • TABLE 122. TACONIC BIOSCIENCES: PRODUCT PORTFOLIO
  • TABLE 123. TACONIC BIOSCIENCES: KEY STRATERGIES
  • TABLE 124. THE JACKSON LABORATORY.: KEY EXECUTIVES
  • TABLE 125. THE JACKSON LABORATORY.: COMPANY SNAPSHOT
  • TABLE 126. THE JACKSON LABORATORY.: PRODUCT SEGMENTS
  • TABLE 127. THE JACKSON LABORATORY.: PRODUCT PORTFOLIO
  • TABLE 128. TRANS GENIC INC.: KEY EXECUTIVES
  • TABLE 129. TRANS GENIC INC.: COMPANY SNAPSHOT
  • TABLE 130. TRANS GENIC INC.: PRODUCT SEGMENTS
  • TABLE 131. TRANS GENIC INC.: PRODUCT PORTFOLIO
  • TABLE 132. JANVIER LABS, LLC: KEY EXECUTIVES
  • TABLE 133. JANVIER LABS, LLC: COMPANY SNAPSHOT
  • TABLE 134. JANVIER LABS, LLC: PRODUCT SEGMENTS
  • TABLE 135. JANVIER LABS, LLC: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. ANIMAL MODEL MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF ANIMAL MODEL MARKET,2022-2032
  • FIGURE 03. TOP INVESTMENT POCKETS IN ANIMAL MODEL MARKET (2023-2032)
  • FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. LOW THREAT OF NEW ENTRANTS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. LOW INTENSITY OF RIVALRY
  • FIGURE 08. LOW BARGAINING POWER OF BUYERS
  • FIGURE 09. GLOBAL ANIMAL MODEL MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 10. ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022 AND 2032(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR RAT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR MICE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR GUINEA PIGS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR RABBITS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. ANIMAL MODEL MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. ANIMAL MODEL MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR PHARMA AND BIOTECH COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. ANIMAL MODEL MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 25. U.S. ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. CANADA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. MEXICO ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. GERMANY ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. FRANCE ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. UK ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. ITALY ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. SPAIN ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. REST OF EUROPE ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. JAPAN ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. CHINA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. AUSTRALIA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. INDIA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SOUTH KOREA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. BRAZIL ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. SAUDI ARABIA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. SOUTH AFRICA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. REST OF LAMEA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 48. COMPETITIVE DASHBOARD
  • FIGURE 49. COMPETITIVE HEATMAP: ANIMAL MODEL MARKET
  • FIGURE 50. TOP PLAYER POSITIONING, 2022
  • FIGURE 51. CHARLES RIVER LABORATORIES: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 52. CHARLES RIVER LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 53. CHARLES RIVER LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 54. INOTIV, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 55. INOTIV, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 56. INOTIV, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 57. TRANS GENIC INC.: NET REVENUE, 2020-2022 ($MILLION)